Market Overview:
The global genome editing/genome engineering market is expected to grow at a CAGR of 15.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for genetically modified crops and animals, rising prevalence of chronic diseases, and technological advancements in CRISPR-based genome editing tools. However, the high cost of genome editing tools and ethical concerns associated with gene editing may restrain the growth of this market during the forecast period. The global genome Editing/Genome Engineering Market is segmented on the basis of type, application, and region. On the basis of type, it is divided into CRISPR-based genome engineering tools, TALEN-based genome engineering tools ZFN-based Genome Engineering Tools .On The Basis Of Application , It Is Divided Into Cell Line Engineering Animal Genetic Engineering Plant Genetic Engineering .
Product Definition:
Genome Editing/Genome Engineering is the process of artificially modifying the genome of a living organism. The importance of Genome Editing/Genome Engineering is that it can be used to edit and modify genes, which can then be used to treat genetic disorders or diseases.
CRISPR:
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a gene editing tool that enables the modification of any genome with high specificity and efficiency. It is an adaptive immune system for the detection of viral infections. The technology has wide applications in basic research, biotechnology, medicine and agriculture industries.
TALEN:
TALEN (Transcription- Activated Lexical Enrichment) is an enzyme that catalyzes the recognition and binding of RNA polymerase to the tRNA/ITS transcript and promotes polyadenylation. It also plays a major role in processing of lysine, arginine, and histidine gene products from the 3' end of pre- mRNA. The process involves cleavage & extension of pre-mRNA which leads to formation of mature mRNA.
Application Insights:
Cell line engineering application segment accounted for the largest revenue share in 2016 and is projected to continue leading over the forecast period. This is due to its wide applications in various fields such as stem cell research, gene therapy, and cancer research.
CRISPR/Cas9 system has revolutionized genetic engineering by providing an efficient way of editing genomes at specific locations. It can be used not only for modification of DNA but also RNA with high specificity and efficiency. The use of this technology has enabled researchers to modify genes involved in diseases that are passed from parents to offspring such as cystic fibrosis, hemophilia, sickle cell anemia, and others (Sarkar et al., 2017).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a substantial number of genome editing/genome engineering companies, which have been focusing on commercialization of their products for various applications. Moreover, increasing investments by these companies in R&D activities is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising awareness among people regarding advanced healthcare facilities and treatments along with growing disposable income levels in emerging economies such as China and India. In addition, government initiatives for development of healthcare infrastructure are also expected favorably impact industry growth during the projected time frame. ‰â€˜”©â€™ Genomics Ltd.
Growth Factors:
- Increasing demand for genetically modified crops
- Rising prevalence of genetic disorders and chronic diseases
- Growing investments in genome editing research
- Advances in CRISPR technology
- Proliferation of precision medicine
Scope Of The Report
Report Attributes
Report Details
Report Title
Genome Editing/Genome Engineering Market Research Report
By Type
CRISPR, TALEN, ZFN
By Application
Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering
By Companies
Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, Crispr Therapeutics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
228
Number of Tables & Figures
160
Customization Available
Yes, the report can be customized as per your need.
Global Genome Editing/Genome Engineering Market Report Segments:
The global Genome Editing/Genome Engineering market is segmented on the basis of:
Types
CRISPR, TALEN, ZFN
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cell Line Engineering, Animal Genetic Engineering, Plant Genetic Engineering
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Merck
- Horizon Discovery
- Genscript
- Sangamo Biosciences
- Integrated Dna Technologies
- Lonza
- New England Biolabs
- Origene Technologies
- Transposagen Biopharmaceuticals
- Editas Medicine
- Crispr Therapeutics
Highlights of The Genome Editing/Genome Engineering Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CRISPR
- TALEN
- ZFN
- By Application:
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genome Editing/Genome Engineering Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Genome editing is the process of altering the sequence of a gene, either by using enzymes or other methods. Genome engineering is the process of adding, deleting or changing genes in a genome outside of natural selection.
Some of the key players operating in the genome editing/genome engineering market are Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs, Origene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, Crispr Therapeutics.
The genome editing/genome engineering market is expected to grow at a compound annual growth rate of 15.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genome Editing/Genome Engineering Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genome Editing/Genome Engineering Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genome Editing/Genome Engineering Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genome Editing/Genome Engineering Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genome Editing/Genome Engineering Market Size & Forecast, 2020-2028
4.5.1 Genome Editing/Genome Engineering Market Size and Y-o-Y Growth
4.5.2 Genome Editing/Genome Engineering Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 CRISPR
5.2.2 TALEN
5.2.3 ZFN
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cell Line Engineering
6.2.2 Animal Genetic Engineering
6.2.3 Plant Genetic Engineering
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genome Editing/Genome Engineering Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genome Editing/Genome Engineering Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 CRISPR
9.6.2 TALEN
9.6.3 ZFN
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cell Line Engineering
9.10.2 Animal Genetic Engineering
9.10.3 Plant Genetic Engineering
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 CRISPR
10.6.2 TALEN
10.6.3 ZFN
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cell Line Engineering
10.10.2 Animal Genetic Engineering
10.10.3 Plant Genetic Engineering
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 CRISPR
11.6.2 TALEN
11.6.3 ZFN
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cell Line Engineering
11.10.2 Animal Genetic Engineering
11.10.3 Plant Genetic Engineering
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 CRISPR
12.6.2 TALEN
12.6.3 ZFN
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cell Line Engineering
12.10.2 Animal Genetic Engineering
12.10.3 Plant Genetic Engineering
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 CRISPR
13.6.2 TALEN
13.6.3 ZFN
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cell Line Engineering
13.10.2 Animal Genetic Engineering
13.10.3 Plant Genetic Engineering
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genome Editing/Genome Engineering Market: Competitive Dashboard
14.2 Global Genome Editing/Genome Engineering Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 Merck
14.3.3 Horizon Discovery
14.3.4 Genscript
14.3.5 Sangamo Biosciences
14.3.6 Integrated Dna Technologies
14.3.7 Lonza
14.3.8 New England Biolabs
14.3.9 Origene Technologies
14.3.10 Transposagen Biopharmaceuticals
14.3.11 Editas Medicine
14.3.12 Crispr Therapeutics
